½ÃÀ庸°í¼­
»óǰÄÚµå
1595134

¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå : À¯Çüº°, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Ovulation Predictor Kits Market by Type (Saliva-Based, Urine-Based), Application (Clinics, Diagnostic Centers, Fertility Centers) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¹è¶õ ¿¹Ãø ŰƮ ½ÃÀåÀº 2023³â¿¡ 2¾ï 6,463¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 2¾ï 8,564¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.03%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 4¾ï 5,446¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­(OPK)´Â ºÒÀÓ ¹× ¿©¼º °Ç°­ ½ÃÀå¿¡¼­ Áß¿äÇÑ ºÎ¹®À» Çü¼ºÇϰí ÀÖÀ¸¸ç, ¿ù°æÁÖ±â Áß Àӽа¡´É¼ºÀÌ °¡Àå ³ôÀº ½Ã±â¸¦ ÆÄ¾ÇÇÏ´Â µ¥ µµ¿òÀÌ µÇµµ·Ï °í¾ÈµÇ¾ú½À´Ï´Ù. ÀÌ Å°Æ®´Â ¼Òº¯ ³» ȲüÇü¼ºÈ£¸£¸ó(LH) ¼öÄ¡ÀÇ ±Þ°ÝÇÑ »ó½ÂÀ» °¨ÁöÇÏ¿© ÀӽŠ½Ã±â¸¦ Á¤È®ÇÏ°Ô ÃøÁ¤ÇÏ´Â µ¥ Áß¿äÇÑ ÅëÂû·ÂÀ» Á¦°øÇϸç, OPKÀÇ Çʿ伺Àº ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ´õ¿í °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ºÒÀÓ Ä¡·á °ü±¤ Áõ°¡, °æ·Â´ÜÀý·Î ÀÎÇÑ ÀӽŠÁö¿¬, °èȹÀûÀÎ À°¾Æ¿¡ ´ëÇÑ ¼±È£ µîÀ¸·Î ÀÔÁõµÇ°í ÀÖÀ¸¸ç, OPK´Â ÀÚ¿¬ ÀÓ½ÅÀ» ½ÃµµÇÏ´Â ºÎºÎ, ¿ù°æ °Ç°­ »óŸ¦ ¸ð´ÏÅ͸µÇÏ´Â ¿©¼º, º¸Á¶ »ý½Ä ÀǷḦ Áö¿øÇϴ Ŭ¸®´Ð µî¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ë ºÐ¾ß´Â ÁÖ·Î °¡Á¤°ú ºÒÀÓ Å¬¸®´ÐÀÔ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ºÒÀÓ·ü Áõ°¡, µðÁöÅÐ °Ç°­ ¼Ö·ç¼ÇÀÇ ¹ßÀü, »ý½Ä °Ç°­ ±³À°¿¡ ´ëÇÑ °ü½É Áõ°¡À̸ç, OPK¸¦ ½º¸¶Æ®Æù ¾Û¿¡ ÅëÇÕÇÏ¿© °³ÀÎÈ­µÈ ºÒÀÓ ÃßÀûÀ» Á¦°øÇÒ ¼ö ÀÖ´Â ±âȸ°¡ ±ÞÁõÇϰí ÀÖ¾î ½ÃÀå ±â¾÷¿¡°Ô °­·ÂÇÑ ¼ö´ÜÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ºÒÀÓ ¹®Á¦¸¦ ³íÀÇÇÏ´Â µ¥ ÀÖ¾î »çȸ¹®È­Àû À庮, °³¹ßµµ»ó±¹¿¡¼­ÀÇ Á¦ÇÑµÈ Á¢±Ù¼º, ÷´Ü ºÒÀÓ ¸ð´ÏÅÍ¿Í °°Àº ´ëü ºÒÀÓ ÃßÀû ¹æ¹ý°úÀÇ °æÀï µî ¿©·¯ °úÁ¦°¡ Á¸ÀçÇÕ´Ï´Ù. ¶ÇÇÑ, À§¾ç¼º ¶Ç´Â À½¼º °á°ú´Â »ç¿ëÀÚÀÇ ½Å·Ú¸¦ ¶³¾î¶ß¸± ¼ö ÀÖ½À´Ï´Ù. ºñħ½ÀÀû, ½Ç½Ã°£ ºñÀӽŠÃßÀû±â °³¹ßÀ̳ª AI ÅëÇÕÀ» ÅëÇÑ Á¤È®µµ Çâ»ó°ú °°Àº Çõ½ÅÀº Å« ¼ºÀåÀÇ ±æÀ» Á¦½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­´Â °¡°Ý ¹× Á¢±Ù¼º¿¡ ÃÊÁ¡À» ¸ÂÃß¸é µµ´Þ ¹üÀ§¿Í äÅÃÀÌ È®´ëµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ð¹ÙÀÏ Çコ Ç÷§Æû°úÀÇ Çù¾÷À» ÅëÇØ »õ·Î¿î ÆÇ¸Å ä³ÎÀ» °³Ã´ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­ÇÏÁö¸¸, Çõ½ÅÀÇ ±âȸ´Â ¹«¸£ÀͰí ÀÖÀ¸¸ç, ƯÈ÷ »ç¿ëÀÚ °æÇè °³¼±°ú ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ ¼ÒºñÀÚ ±³À° È®´ë°¡ Áß¿äÇÕ´Ï´Ù. ¿øÈ°ÇÑ »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º¸¦ µµÀÔÇϰí OPK¿Í ÇÔ²² Á¾ÇÕÀûÀÎ »ý½Ä ÀÇ·á ¼Ö·ç¼ÇÀ» ÅëÇÕÇÏ¸é ½ÃÀå¿¡¼­ È®°íÇÑ À§Ä¡¸¦ È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. °³ÀÎÈ­ ºÐ¼® ¹× ¿¹Ãø ºÐ¼® ¿¬±¸¿¡ ÁßÁ¡À» µÎ¾î ¼ÒºñÀÚ Âü¿©¸¦ ´õ¿í Çõ½ÅÇÏ°í ½ÃÀå È®ÀåÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 2¾ï 6,463¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 2¾ï 8,564¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 4¾ï 5,446¸¸ ´Þ·¯
CAGR(%) 8.03%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¹è¶õ ¿¹Ãø ŰƮ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °Ç°­ ¹®Á¦·Î ÀÎÇÑ ÀӽŠÁö¼ÓÀÇ Çʿ伺 Áõ´ë
    • ÀÓ»êºÎÀÇ °í·ÉÈ­ ¹× °¡Á·°èȹ °³³ä Áõ°¡
    • ´Ù¸¥ ¹æ¹ý¿¡ ºñÇØ Á¤È®ÇÏ°í Æí¸®ÇÏ°Ô »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ƯÁ¤ ¹è¶õÀ¯µµÁ¦°¡ ½Ã½ºÅÛ ³»¿¡ Á¸ÀçÇÒ °æ¿ì, ºñ¿ëÀÌ ºñ½Î°í È¿°ú°¡ ¾ø½À´Ï´Ù.
  • ½ÃÀå ±âȸ
    • ½ÅÈï±¹Àº »õ·Î¿î ¼ºÀåÀÇ ±æÀ» Á¦°øÇÕ´Ï´Ù.
    • ¹è¶õ ¹× ÀӽŠÀÌÁß °Ë»ç¸¦À§ÇÑ º¹ÇÕ Å°Æ®ÀÇ ÃâÇö
  • ½ÃÀå °úÁ¦
    • ¹è¶õ ¿¹Ãø ŰƮ´Â ¹è¶õ °Ë»ç¿¡ ÇѰ谡 ÀÖ¾î 40¼¼ ÀÌ»ó ¿©¼º¿¡°Ô´Â È¿°ú°¡ ³·½À´Ï´Ù.

Portre's Five Forces: ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå °ø·«À» À§ÇÑ Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

¹è¶õ ¿¹Ãø ŰƮ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå ¼º°øÀÇ ±æÀ» ±×¸®´Ù.

¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå : À¯Çüº°

  • Ÿ¾× ±â¹Ý
  • ¼Òº¯ ±â¹Ý

Á¦7Àå ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå : ¿ëµµº°

  • Ŭ¸®´Ð
  • Áø´Ü¼¾ÅÍ
  • ºÒÀÓÄ¡·á ¼¾ÅÍ
  • ȨÄɾî
  • º´¿ø

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¹è¶õ ¿¹Ãø ŰƮ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • AdvaCare Pharma USA
  • AVA Sciences-FMTC LLC
  • ConceiveEasy, Inc.
  • Everly Well, Inc.
  • Fairhaven Health
  • Fertility Collection
  • Geratherm Medical AG
  • Hangzhou Singclean Medical Products Co. Ltd.
  • Mosie LLC
  • Nectar Lifesciences Ltd.
  • Piramal Pharma Ltd.
  • Prima Lab SA
  • Quanovate Tech Inc.
  • Roman Health Ventures Inc.
  • Swiss Precision Diagnostics GmBH
  • The Boots Company PLC
LSH

The Ovulation Predictor Kits Market was valued at USD 264.63 million in 2023, expected to reach USD 285.64 million in 2024, and is projected to grow at a CAGR of 8.03%, to USD 454.46 million by 2030.

Ovulation Predictor Kits (OPKs) form a vital segment within the fertility and women's health market, designed to aid in identifying the most fertile period during a menstrual cycle. These kits detect the surge in luteinizing hormone (LH) levels in urine, providing insights crucial for timing conception efforts accurately. The necessity for OPKs is underscored by the growing awareness around fertility management, evidenced by increasing fertility tourism, delayed pregnancies due to career commitments, and a preference for planned parenthood. OPKs find applications among couples attempting to conceive naturally, women monitoring menstrual health, and clinics supporting assisted reproductive technologies. End-use sectors predominantly involve households and fertility clinics. Market growth is driven by the rise in infertility rates, advancements in digital health solutions, and increased emphasis on reproductive health education. Opportunities have surged with the integration of OPKs into smartphone apps that offer personalized fertility tracking, which presents a potent avenue for market players. However, challenges such as socio-cultural barriers in discussing fertility issues, limited access in developing regions, and competition from alternative fertility tracking methods like advanced fertility monitors exist. Moreover, false-positive or negative results can deter trust among users. Innovations like developing non-invasive, real-time fertility trackers and enhancing accuracy with AI integration could present significant growth avenues. Focusing on affordability and accessibility, especially in emerging markets, could expand reach and adoption. Additionally, collaborations with mobile health platforms can open new distribution channels. The market is competitive yet ripe for innovation, particularly enhancing user experience and expanding consumer education on fertility health. Incorporating seamless user interfaces and integrating comprehensive reproductive health solutions alongside OPKs can ensure robust market positioning. Emphasizing research on personalized and predictive analytics could further revolutionize consumer engagement and drive market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 264.63 million
Estimated Year [2024] USD 285.64 million
Forecast Year [2030] USD 454.46 million
CAGR (%) 8.03%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ovulation Predictor Kits Market

The Ovulation Predictor Kits Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need of sustaining a pregnancy due to health issues
    • Increasing incidences of advanced maternal age and family planning concept
    • Precise and more convenient in using as compared to other methods
  • Market Restraints
    • Costly do not work when certain fertility drugs are present in the system
  • Market Opportunities
    • Emerging nations to offer new growth avenues
    • Advent of combined kits for dual test of ovulation and pregnancy
  • Market Challenges
    • Ovulation prediction kits limitation to test for ovulation and less effective on women over 40

Porter's Five Forces: A Strategic Tool for Navigating the Ovulation Predictor Kits Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ovulation Predictor Kits Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ovulation Predictor Kits Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ovulation Predictor Kits Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ovulation Predictor Kits Market

A detailed market share analysis in the Ovulation Predictor Kits Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ovulation Predictor Kits Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ovulation Predictor Kits Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ovulation Predictor Kits Market

A strategic analysis of the Ovulation Predictor Kits Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ovulation Predictor Kits Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma USA, AVA Sciences-FMTC LLC, ConceiveEasy, Inc., Everly Well, Inc., Fairhaven Health, Fertility Collection, Geratherm Medical AG, Hangzhou Singclean Medical Products Co. Ltd., Mosie LLC, Nectar Lifesciences Ltd., Piramal Pharma Ltd., Prima Lab SA, Quanovate Tech Inc., Roman Health Ventures Inc., Swiss Precision Diagnostics GmBH, and The Boots Company PLC.

Market Segmentation & Coverage

This research report categorizes the Ovulation Predictor Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Saliva-Based and Urine-Based.
  • Based on Application, market is studied across Clinics, Diagnostic Centers, Fertility Centers, Home Care, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need of sustaining a pregnancy due to health issues
      • 5.1.1.2. Increasing incidences of advanced maternal age and family planning concept
      • 5.1.1.3. Precise and more convenient in using as compared to other methods
    • 5.1.2. Restraints
      • 5.1.2.1. Costly do not work when certain fertility drugs are present in the system
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging nations to offer new growth avenues
      • 5.1.3.2. Advent of combined kits for dual test of ovulation and pregnancy
    • 5.1.4. Challenges
      • 5.1.4.1. Ovulation prediction kits limitation to test for ovulation and less effective on women over 40
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ovulation Predictor Kits Market, by Type

  • 6.1. Introduction
  • 6.2. Saliva-Based
  • 6.3. Urine-Based

7. Ovulation Predictor Kits Market, by Application

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Diagnostic Centers
  • 7.4. Fertility Centers
  • 7.5. Home Care
  • 7.6. Hospitals

8. Americas Ovulation Predictor Kits Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Ovulation Predictor Kits Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Ovulation Predictor Kits Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AdvaCare Pharma USA
  • 2. AVA Sciences-FMTC LLC
  • 3. ConceiveEasy, Inc.
  • 4. Everly Well, Inc.
  • 5. Fairhaven Health
  • 6. Fertility Collection
  • 7. Geratherm Medical AG
  • 8. Hangzhou Singclean Medical Products Co. Ltd.
  • 9. Mosie LLC
  • 10. Nectar Lifesciences Ltd.
  • 11. Piramal Pharma Ltd.
  • 12. Prima Lab SA
  • 13. Quanovate Tech Inc.
  • 14. Roman Health Ventures Inc.
  • 15. Swiss Precision Diagnostics GmBH
  • 16. The Boots Company PLC
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦